Skip to main content
SpringerLink
Log in

The Role of mGluR5 in the Effects of Cocaine Implications for Medication Development

  • Chapter
Glutamate and Addiction

Part of the book series: Contemporary Clinical Neuroscience ((CCNE))

  • 228 Accesses

Abstract

Investigations over the past several years have yielded insights into the contributions of metabotropic glutamate receptors (mGluRs) to the effects of psychostimulants. Recently, an important role was demonstrated for the mGluR subtype 5 in the locomotor stimulant and reinforcing effects of cocaine (1). The data obtained in that report will be summarized here, followed by a brief discussion of the implications of this evidence for the development of medications to treat cocaine dependence.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Chiamulera, C., Epping-Jordan, M. R, Zocchi, A., Marcon, C., Cottiny, C., Tacconi, S., Corsi, M., Orzi, F., and Conquet, F. (2001) Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nature Neurosci. 4, 873 - 874.

    Article  PubMed  CAS  Google Scholar 

  2. Nakanishi., S. (1992) Molecular diversity of glutamate receptors and implications for brain function. Science 258, 597 - 603.

    Article  Google Scholar 

  3. Conn, J. R. and Pin, J.-P. (1997) Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 37, 205-237.

    Article  PubMed  CAS  Google Scholar 

  4. Albin R. L., Makowiec R. L., Hollingsworth Z., Dure L. S., Penney J. B., and Young, A. B. (1992) Excitatory amino acid binding sites in the basal ganglia of the rat: a quantitiative autoradiographic study. Neuroscience 46, 35 - 48.

    Article  PubMed  CAS  Google Scholar 

  5. Shigemoto R., Nakanishi S., and Mizuno N. (1992) Distribution of the mRNA for a metabotropic glutamate receptor (mGluR1) in the central nervous system: an in situ hybridization study in adult and developing rat. J. Comp. Neurol. 322, 121-135.

    Article  PubMed  CAS  Google Scholar 

  6. Ohishi H., Shigemoto R., Nakanishi S., and Mizuno N. (1993) Distribution of the mRNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat. Neuroscience 53, 1009 - 1018.

    Article  PubMed  CAS  Google Scholar 

  7. Ohishi H., Shigemoto R., Nakanishi S., and Mizuno N. (1993) Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: an in situ hybridization study. J. Comp. Neurol. 335, 252-266.

    Article  PubMed  CAS  Google Scholar 

  8. Testa, C. M., Standaert, D. G., Young, A. B., and Penney, J. B. (1994) Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat. J. Neurosci. 14, 3005 - 3018.

    PubMed  CAS  Google Scholar 

  9. Romano, C., Sesma, M. A., McDonald, C. T., O Malley, K. L., Van den Pol, A. N., and Olney, J. W. (1995) Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. J. Comp. Neurol. 355, 455-469.

    Article  Google Scholar 

  10. Tallaksen-Greene, S. J., Kaatz, K. W., Romano, C., and Albin, R. L. (1998) Localization of mGluR1a-like immunoreactivity and mGluR5-like immunoreactivity in identified populations of striatal neurons. Brain Res. 780, 210 - 217.

    Article  PubMed  CAS  Google Scholar 

  11. Vezina, P., and Kim J. H., (1999) Metabotropic glutamate receptors and the generation of locomotor activity: interactions with brain dopamine. Neurosci. Biobehay. Rev. 23, 577-589.

    Article  CAS  Google Scholar 

  12. Swanson, C. J., and Kalivas, R W. (2000) Regulation of locomotor activity by metabotropic glutamate receptors in the nucleus accumbens and ventral tegmental area. J. Pharmacol. Exp. Ther. 292, 406-414.

    PubMed  CAS  Google Scholar 

  13. Kim, J. H., and Vezina, R. (1998) Metabotropic glutamate receptors in the rat nucleus accumbens contribute to amphetamine-induced locomotion. J. Pharmacol. Exp. Ther. 284, 317-322.

    PubMed  CAS  Google Scholar 

  14. Lu, X-Y., Ghasemzadeh, M. B., and Kalivas, R. W. (1999) Expression of glutamate receptor subunit/subtype messenger RNAs for NMDAR1, G1uR1, Glur2 and mGluR5 by accumbal projection neurons. Molecular Brain Res. 63, 287 - 296.

    Article  CAS  Google Scholar 

  15. Ghasemzadeh, M. B., Nelson, L. C., Lu, X. Y., and Kalivas, R. W. (1999) Neuroadaptations in ionotropic and metabotropic glutamate receptor mRNA produced by cocaine treatment. J. Neurochem. 72, 157 - 165.

    Article  PubMed  CAS  Google Scholar 

  16. Swanson, C. J., Baker, D. A., Carson, D., Worley, R F., and Kalivas, R. W. (2001) Repeated cocaine attenuates Group I metabotropic glutamate receptor-mediated glutamate release and behavioral activation: A potential role for Homer. J. Neurosci. 21, 9043-9052.

    Google Scholar 

  17. Gasparini, F., Lingenhohl, K., Stoehr, N., et al. (1999) 2-Methyl-6-(phenyletynyl)-pyridine (MPEP), a potent, selective, and systemically active mGlu5 receptor antagonist. Neuropharmacology 38, 1493 - 1503.

    Google Scholar 

  18. Robinson, T. E. (1984) Behavioral sensitization: characterization of enduring changes in rotational behavioral produced by intermittent injections of amphetamine in male and female rats. Psychopharmacology 84, 466 - 475.

    Article  PubMed  CAS  Google Scholar 

  19. Koob, G. F., Sanna, P. R, and Bloom, E. E. (1998) Neuroscience of addiction. Neuron 21, 467 - 476.

    Article  PubMed  CAS  Google Scholar 

  20. Zocchi, A., Orsini, C., Cabib, S., and Puglisi-Allegra, S. (1998) Parallel strain-dependent effect of amphetamine on locomotor activity and dopamine release in the nucleus accumbens: an in vivo study in mice. Neuroscience 82, 521 - 528.

    Article  PubMed  CAS  Google Scholar 

  21. White, F. J., and Kalivas, E W. (1998) Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend. 51, 141 - 153.

    Article  PubMed  CAS  Google Scholar 

  22. Page, G., Peeters, M., Najimi, M., Maloteaux J-M., and Hermans, E. (2001) Modulation of the neuronal dopamine transporter activity by the metabotropic glutamate receptor mGluR5 in rat striatal synaptosomes through phosphorylation mediated processes. J. Neurochem. 76, 1282 - 1290.

    Article  PubMed  CAS  Google Scholar 

  23. Wang, J., and Johnson, K. M. (1995) Regulation of striatal cyclic-3,5-adenosine monophosphate accumulation and GABA release by glutamate metabotropic and dopaminergic receptors. J. Pharmacol. Exp. Ther. 275, 877-884.

    PubMed  CAS  Google Scholar 

  24. Paolillo, M., Montecucco, A., Zanassi, P., and Schinelli, S. (1998) Potentiation of dopamine-induced cAMP formation by group I metabotropic glutamate receptors via protein kinase C in cultured striatal neurons. Eur. J. Neurosci. 10, 1937-1945.

    Article  PubMed  CAS  Google Scholar 

  25. Liu, F., Ma, X-H., Ule, J., et al. (2001) Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors. Proc. Nat. Acad. Sci. USA 98, 11062-11068.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Mark P. Epping-Jordan PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Clinical Medical Branch, Division of Treatment Research and Development, National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), Bethesda, MD, USA

    Barbara H. Herman PhD

  2. Pharmacology, Integrative & Cellular Neurobiology Research Branch (PICNRB), Division of Neuroscience & Behavioral Research (DNBR), National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), Bethesda, MD, USA

    Jerry Frankenheim PhD

  3. Treatment Research Branch, Division of Clinical and Prevention Research, National Institute on Drug Abuse (NIAAA), National Institutes of Health (NIH), Bethesda, MD, USA

    Raye Z. Litten PhD

  4. Division of Neuropharmacological Drug Products Center for Drug Evaluation and Research, Office of Drug Evaluation I, Food and Drug Administration, Rockville, MD, USA

    Philip H. Sheridan MD

  5. Laboratory of Molecular and Cellular Neurobiology, Division of Intramural Clinical and Biological Research, National Institute on Drug Abuse (NIAAA) National Institutes of Health (NIH), Bethesda, MD, USA

    Forrest F. Weight MD

  6. Division of Treatment Research and Development, National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), Bethesda, MD, USA

    Steven R. Zukin MD

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

Epping-Jordan, M.P. (2002). The Role of mGluR5 in the Effects of Cocaine Implications for Medication Development. In: Herman, B.H., Frankenheim, J., Litten, R.Z., Sheridan, P.H., Weight, F.F., Zukin, S.R. (eds) Glutamate and Addiction. Contemporary Clinical Neuroscience. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-306-4_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-306-4_18

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-234-6

  • Online ISBN: 978-1-59259-306-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation